Skip to main content
Top
Published in: Strahlentherapie und Onkologie 10/2014

01-10-2014 | Original article

Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity

A multicentric pooled analysis of long-term outcomes

Authors: Felipe A. Calvo, M.D., Ph.D., Claudio V. Sole, M.D., Alfredo Polo, M.D., Ph.D., Mauricio Cambeiro, M.D., Ph.D., Angel Montero, M.D., Ana Alvarez, M.D., Miguel Cuervo, M.D., Mikel San Julian, M.D., Rafael Martinez-Monge, M.D., Ph.D.

Published in: Strahlentherapie und Onkologie | Issue 10/2014

Login to get access

Abstract

Background or purpose

A joint analysis of data from three contributing centres within the intraoperative electron-beam radiation therapy (IOERT) Spanish program was performed to investigate the main contributions of IORT to the multidisciplinary treatment of high-risk extremity soft tissue sarcoma (STS).

Methods and materials

Patients with an histologic diagnosis of primary extremity STS, with absence of distant metastases, undergoing limb-sparing surgery with radical intent, external beam radiotherapy (median dose 45 Gy) and IOERT (median dose 12.5 Gy) were considered eligible for participation in this study.

Results

From 1986–2012, a total of 159 patients were analysed in the study from three Spanish institutions. With a median follow-up time of 53 months (range 4–316 years), 5-year local control (LC) was 82 %. The 5-year IOERT in-field control, disease-free survival (DFS) and overall survival (OS) were 86, 62 and 72 %, respectively. On multivariate analysis, only microscopically involved margin (R1) resection status retained significance in relation to LC (HR 5.20, p < 0.001). With regard to IOERT in-field control, incomplete resection (HR 4.88, p = 0.001) and higher IOERT dose (≥ 12.5 Gy; HR 0.32, p = 0.02) retained a significant association in multivariate analysis.

Conclusion

From this joint analysis emerges the fact that an IOERT dose ≥ 12.5 Gy increases the rate of IOERT in-field control, but DFS remains modest, given the high risk of distant metastases. Intensified local treatment needs to be tested in the context of more efficient concurrent, neo- and adjuvant systemic therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Haas RL, Delaney TF, O’Sullivan B (2012) Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys 84:572–580PubMedCrossRef Haas RL, Delaney TF, O’Sullivan B (2012) Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? Int J Radiat Oncol Biol Phys 84:572–580PubMedCrossRef
2.
go back to reference Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305PubMedCrossRefPubMedCentral Rosenberg SA, Tepper J, Glatstein E et al (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305PubMedCrossRefPubMedCentral
3.
go back to reference Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859PubMed Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859PubMed
4.
go back to reference Yang JC, Chang AE, Baker AR et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197PubMed Yang JC, Chang AE, Baker AR et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197PubMed
5.
go back to reference Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679PubMed Pisters PW, Leung DH, Woodruff J et al (1996) Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14:1679PubMed
6.
go back to reference Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530PubMedCrossRef Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530PubMedCrossRef
7.
go back to reference Al Yami AG, Ferguson PC et al (2010) Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys 77:1191PubMedCrossRef Al Yami AG, Ferguson PC et al (2010) Positive surgical margins in soft tissue sarcoma treated with preoperative radiation: is a postoperative boost necessary? Int J Radiat Oncol Biol Phys 77:1191PubMedCrossRef
8.
go back to reference Delaney TF (2012) Radiation therapy: neoadjuvant, adjuvant, or not at all. Surg Oncol Clin N Am 21:215–241PubMedCrossRef Delaney TF (2012) Radiation therapy: neoadjuvant, adjuvant, or not at all. Surg Oncol Clin N Am 21:215–241PubMedCrossRef
9.
go back to reference Zagars GK, Ballo MT, Benjamin RS et al (2003) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747PubMedCrossRef Zagars GK, Ballo MT, Benjamin RS et al (2003) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: Analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747PubMedCrossRef
10.
go back to reference Davis AM, O’Sullivan B, Pater J et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53PubMedCrossRef Davis AM, O’Sullivan B, Pater J et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53PubMedCrossRef
11.
go back to reference Gunderson LL, Willet CG, Calvo FA, Harrison LB (2011) Intraoperative irradiation techniques and results. Current Clinical Oncology. Humana Press. Second edition Gunderson LL, Willet CG, Calvo FA, Harrison LB (2011) Intraoperative irradiation techniques and results. Current Clinical Oncology. Humana Press. Second edition
12.
go back to reference Pascau J, Santos Miranda JA et al (2012) An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys 3:287–295 Pascau J, Santos Miranda JA et al (2012) An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys 3:287–295
13.
go back to reference Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346PubMedCrossRef Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346PubMedCrossRef
14.
go back to reference Haddock MG, Petersen IA, Pritchard D et al (1997) IORT in the management of extremity and limb girdle soft tissue sarcomas. Front Radiat Ther Oncol 31:151–152PubMedCrossRef Haddock MG, Petersen IA, Pritchard D et al (1997) IORT in the management of extremity and limb girdle soft tissue sarcomas. Front Radiat Ther Oncol 31:151–152PubMedCrossRef
15.
go back to reference Oertel S, Treiber M, Zahlten-Hinguranage A et al (2006) Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 64:1416–1423PubMedCrossRef Oertel S, Treiber M, Zahlten-Hinguranage A et al (2006) Intraoperative electron boost radiation followed by moderate doses of external beam radiotherapy in limb-sparing treatment of patients with extremity soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 64:1416–1423PubMedCrossRef
16.
go back to reference Azinovic I, Martinez Monge R, Javier Aristu J et al (2003) Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities. Radiother Oncol 67:331–337PubMedCrossRef Azinovic I, Martinez Monge R, Javier Aristu J et al (2003) Intraoperative radiotherapy electron boost followed by moderate doses of external beam radiotherapy in resected soft-tissue sarcoma of the extremities. Radiother Oncol 67:331–337PubMedCrossRef
17.
go back to reference Call JA, Stafford SL, Petersen IA et al (2012) Use of Intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol Oct 29 (Epub ahead of print) Call JA, Stafford SL, Petersen IA et al (2012) Use of Intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol Oct 29 (Epub ahead of print)
18.
go back to reference Dubois JB, Debrigode C, Hay M et al (1995) Intra-operative radiotherapy in soft tissue sarcomas. Radiother Oncol 34:160–163PubMedCrossRef Dubois JB, Debrigode C, Hay M et al (1995) Intra-operative radiotherapy in soft tissue sarcomas. Radiother Oncol 34:160–163PubMedCrossRef
19.
go back to reference Dickie CI, Griffin AM, Parent AL et al (2012) The relationship between local recurrence and radiotherapy treatment volume for soft tissue sarcomas treated with external beam radiotherapy and function preservation surgery. Int J Radiat Oncol Biol Phys 82:1528–1534PubMedCrossRef Dickie CI, Griffin AM, Parent AL et al (2012) The relationship between local recurrence and radiotherapy treatment volume for soft tissue sarcomas treated with external beam radiotherapy and function preservation surgery. Int J Radiat Oncol Biol Phys 82:1528–1534PubMedCrossRef
20.
go back to reference Eckert F, Gani C, Kluba T et al (2013) Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcoma. Strahlenther Onkol 189:482–485PubMedCrossRef Eckert F, Gani C, Kluba T et al (2013) Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcoma. Strahlenther Onkol 189:482–485PubMedCrossRef
21.
go back to reference Pervaiz N, Colterjohn N, Farrokhyar F et al (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113:573–581PubMedCrossRef Pervaiz N, Colterjohn N, Farrokhyar F et al (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113:573–581PubMedCrossRef
22.
go back to reference Kretzler A, Molls M, Gradinger R et al (2004) Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol 180:365–370PubMedCrossRef Kretzler A, Molls M, Gradinger R et al (2004) Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol 180:365–370PubMedCrossRef
Metadata
Title
Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity
A multicentric pooled analysis of long-term outcomes
Authors
Felipe A. Calvo, M.D., Ph.D.
Claudio V. Sole, M.D.
Alfredo Polo, M.D., Ph.D.
Mauricio Cambeiro, M.D., Ph.D.
Angel Montero, M.D.
Ana Alvarez, M.D.
Miguel Cuervo, M.D.
Mikel San Julian, M.D.
Rafael Martinez-Monge, M.D., Ph.D.
Publication date
01-10-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 10/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0640-2

Other articles of this Issue 10/2014

Strahlentherapie und Onkologie 10/2014 Go to the issue